The Comptroller General of Drugs of India (DGCI) on Saturday approved the country’s first Covid-19 Clustered Regularly Interspaced Short Palindromic (CRISPR) test for commercial launch. This is developed by Tata and developed by CSIR-IGIB (Institute for Genomics and Integrative Biology) FELUDA (an acronym for FNCAS9 Editor-Limited Uniform Detection Assay). “The …
Read More »Center allows the commercial launch of the first CRISPR Covid-19 test | All you need to know
